| Circle Home Inc 847 Rogers Street, Suite 201, Lowell, MA, 01852 | |
| (978) 459-9343 |
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| Name | Circle Home Inc |
|---|---|
| Location | 847 Rogers Street, Suite 201, Lowell, Massachusetts |
| Hospice ID | 221516 |
| Category | Part of a Home Health Agency |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| SSA county code | 090 |
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| NPI Number | 1972593697 |
| Organization Name | Circle Home, Inc. |
| Address | 847 Rogers St Lowell, Massachusetts, 01852 |
| Phone Number | (978)805-2651 |
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 88.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 67.2 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 93.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 98.0 | 93.3 |
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| Home Health Aides | 4.71 |
| Counselors | 1 |
| Homemakers | 4.71 |
| Licensed Practical or Vocational Nurses | 0.02 |
| Medical Social Workers | 0.88 |
| Physicians | 0.22 |
| Registered Nurses | 3.31 |
| Other Personnel | 5.16 |
| Total Employees | 20.01 |
|---|
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| Others | 0.36 |
| Total Volunteers | 0.36 |
|---|
News Archive
A 23-year old federal program for the early detection and treatment of cervical cancer markedly reduces illness and death among underserved, low-income women, yet its impact has been reduced by the fact that it has reached only 10 percent of the eligible population, finds a new study in the American Journal of Preventive Medicine.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY™ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
Using recent advances in marine biomechanics, materials science, and tissue engineering, a team of researchers at Harvard University and the California Institute of Technology (Caltech) have turned inanimate silicone and living cardiac muscle cells into a freely swimming "jellyfish."
House Democrats are moving ahead with another round of COVID-19 relief, including additional funding for state Medicaid programs, an open enrollment period for the Affordable Care Act's marketplace plans, and money to pay premiums for newly unemployed Americans to continue on their employer health coverage.
› Verified 7 days ago
| Circle Home Inc Location: 847 Rogers Street, Suite 201, Lowell, Massachusetts, 01852 Phone: (978) 459-9343 |